These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 9673)

  • 21. The effect of non-specific beta-blockade on metabolic and haemostatic variables during hypoglycaemia.
    Mikhailidis DP; Barradas MA; Hutton RA; Jeremy JY; Sabur M; Dandona P
    Diabetes Res; 1985 May; 2(3):127-34. PubMed ID: 2866057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of multiple pharmaco-therapy in the pathogenesis of hyperlipidemia after renal transplantation.
    Chan MK; Varghese Z; Persaud JW; Fernando ON; Moorhead JF
    Clin Nephrol; 1981 Jun; 15(6):309-13. PubMed ID: 6113904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of valium (diazepam) on experimental atherosclerosis in roosters.
    Patel DJ; Wong HY; Newman HA; Nightingale TE; Frasinel C; Johnson FB; Patel S; Coleman B
    Artery; 1982; 10(4):237-49. PubMed ID: 7181670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pharmacology of the optically active isomers of talinolol (cordanum) 2].
    Femmer K; Poppe H
    Pharmazie; 1982 Jul; 37(7):505-8. PubMed ID: 6127726
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of metipranolol and other blockaders of beta-receptors in experimental animals and man].
    Mayer O; Trcka V
    Cas Lek Cesk; 1982 Sep; 121(34-35):1083-6. PubMed ID: 6127161
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparative beta adrenoreceptor blocking effect of propranolol and penbutalol. Preliminary observations.
    Khanna PK; Balasubramanian V; Chatterji JC; Hoon RS
    J Assoc Physicians India; 1978 Mar; 26(3):143-6. PubMed ID: 32165
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect, in obese subjects, of the inhibition of beta-adrenergic receptors on the changes of glycemia, serum free fatty acids and glycerol, produced by glucagon].
    Milcou SM; Radian N; Dinulescou E; Dragomirescou M; Mitrache L; Isaia M
    Rev Fr Endocrinol Clin; 1970; 11(4):303-10. PubMed ID: 4397330
    [No Abstract]   [Full Text] [Related]  

  • 28. Celiprolol: a haemodynamic appraisal in comparison with propranolol.
    Solomon T; Gensini G; Dator C; Caruso F
    Br J Clin Pract Suppl; 1985 Jun; 40():43-4. PubMed ID: 2864062
    [No Abstract]   [Full Text] [Related]  

  • 29. On the clinical pharmacology of talinolol, a new beta 1-adrenoceptor blocking agent.
    Haustein KO; Fiehring H; Oltmanns G; Femmer K
    Int J Clin Pharmacol Biopharm; 1979 Dec; 17(12):465-70. PubMed ID: 43294
    [No Abstract]   [Full Text] [Related]  

  • 30. Protection against isoprenaline induced myocardial necroses by beta-adrenergic blocking agents.
    Kulig A; Kostka-Trabka E; Gryglewski R
    Pol J Pharmacol Pharm; 1973; 25(1):85-90. PubMed ID: 4149575
    [No Abstract]   [Full Text] [Related]  

  • 31. The actions of the beta-adrenoceptor blocking agents propranolol and metoprolol in the maximally exercised horse.
    Snow DH; Summers RJ; Guy PS
    Res Vet Sci; 1979 Jul; 27(1):22-9. PubMed ID: 574307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Myocardial consumption of free fatty acids and carbohydrates following treatment with a new beta-blockader (1-o-methoxyphenoxy-3-isopropylamino-2-propanol HC1) D 1601].
    Marchetti G; Merlo L; Noseda V
    Boll Soc Ital Cardiol; 1973; 18(7):672-5. PubMed ID: 4157148
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of adrenergic beta-blockade using trimepranol on glucose, insulin, somatotropin and nonesterified fatty acids in the blood of women with diabetes mellitus].
    Felt V; Nedvídkrová J; Hortová O
    Vnitr Lek; 1974 Nov; 20(11):1050-4. PubMed ID: 4155166
    [No Abstract]   [Full Text] [Related]  

  • 34. [Action of various beta adrenolytic agents on the alpha blocking properties of yohimbine in the dog].
    Mouillé P; Cheymol G
    C R Seances Soc Biol Fil; 1973; 167(3):440-2. PubMed ID: 4150410
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of pindolol on the metabolic activities of adrenaline].
    Schmitt H; Lucet B
    C R Seances Soc Biol Fil; 1970; 164(11):2193-5. PubMed ID: 4399994
    [No Abstract]   [Full Text] [Related]  

  • 36. Regression and prevention of experimental atherosclerosis: effects of diet and bile diversion in the dog.
    DePalma RG; Hubay CA; Vogt CJ; Insull W; Hartman PH; Robinson AV
    Surg Forum; 1968; 19():308-10. PubMed ID: 5718642
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of talinolol and the optical isomers of propranolol on LCAT activity in vitro.
    Schauer I; Schauer UJ; Thielmann K
    Int J Clin Pharmacol Ther Toxicol; 1984 Nov; 22(11):608-10. PubMed ID: 6548729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of beta-adrenergic blocking agents on serum lipids.
    Lloyd-Mostyn RH; Lefevre D; Lord PS; Doig E; Krikler DM
    Atherosclerosis; 1971; 14(2):283-7. PubMed ID: 4399102
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effect of beta-adrenergic blocking agents on 14C-leucine incorporation into proteins in nervous tissue (author's transl)].
    Machová J; Faberová V; Beno M
    Bratisl Lek Listy; 1981 Jul; 76(1):11-20. PubMed ID: 6114787
    [No Abstract]   [Full Text] [Related]  

  • 40. [Influence of beta-blocking agents on experimental atherosclerosis of cocks (author's transl)].
    Reinis Z; Lojda Z; Heyrovský A; Horáková D; Reisenauer R
    Cas Lek Cesk; 1975 Oct; 114(43):1320-5. PubMed ID: 146
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.